Alvotech Warrant (ALVOW) Financials
Newest figures come from the 10-K for FY2025, filed Mar 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALVOW SEC filings page.
Alvotech Warrant (ALVOW) reported $586.3M in revenue for fiscal year 2025, up 19.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Alvotech’s dominant mechanic is a rapid commercialization shift: reported profit has arrived, but operations still consume cash and financing remains central.
The 2025 profit of$27.9M coexisted with operating cash flow of-$50.2M , so reported earnings had not yet become cash. Cash conversion nevertheless improved from operating cash flow of-$236.8M in FY2024, indicating a narrowing gap rather than a completed transition to self-funding.
Revenue reached
FY2025 liabilities of
Financial Health Signals
Alvotech Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Alvotech Warrant passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Alvotech Warrant used $1.80 of operating cash (-$50.2M OCF vs $27.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Alvotech Warrant held $172.4M in cash against $138.0M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
ALVOW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
ALVOW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q2'2510-Q | Q4'2410-K | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5B+21.8% | $1.4B+30.3% | $1.2B+28.6% | $1.1B+17.3% | $950.1M+14.7% | $910.7M | $828.4M+38.5% | $598.0M |
| Current Assets | $574.0M+26.2% | $509.5M+78.6% | $455.0M+133.5% | $285.2M+34.6% | $194.8M-15.6% | $211.9M | $230.7M+92.6% | $119.8M |
| Cash & Equivalents | $172.4M+235.1% | $151.5M+1283.9% | $51.4M+360.9% | $10.9M-81.9% | $11.2M-83.2% | $60.5M | $66.4M+278.4% | $17.6M-44.6% |
| Inventory | $220.1M+72.1% | $155.5M+61.0% | $127.9M+71.8% | $96.6M+21.7% | $74.4M+4.1% | $79.4M | $71.5M+83.0% | $39.1M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | $16.3M | $33.0M | N/A |
| Goodwill | $12.8M+13.3% | $12.8M+9.4% | $11.3M-6.0% | $11.7M-1.6% | $12.1M+3.6% | $11.9M | $11.6M-5.9% | $12.4M-7.9% |
| Total Liabilities | $1.8B+8.4% | $1.6B-6.5% | $1.6B-13.2% | $1.7B+20.5% | $1.9B+35.2% | $1.4B | $1.4B+89.9% | $733.6M |
| Current Liabilities | $304.1M+57.2% | $279.7M-76.7% | $193.4M-25.9% | $1.2B+442.4% | $260.9M+56.0% | $221.7M | $167.3M+49.6% | $111.8M |
| Non-Current Liabilities | $1.5B+1.9% | $1.3B+172.6% | $1.4B-11.2% | $471.9M-59.6% | $1.6B+32.3% | $1.2B | $1.2B+97.1% | $621.8M |
| Long-Term Debt | $138.0M+23.1% | $136.3M+11.8% | $112.1M+6.2% | $121.9M+39.4% | $105.6M+198.7% | $87.4M | $35.4M-69.2% | $114.8M-79.8% |
| Total Equity | -$284.5M+31.1% | -$173.3M+71.4% | -$412.8M+55.7% | -$605.9M-26.6% | -$932.5M-65.2% | -$478.5M | -$564.4M-316.2% | -$135.6M+84.4% |
| Retained Earnings | -$2.4B+1.1% | -$2.3B+2.7% | -$2.4B-10.5% | -$2.4B-35.5% | -$2.2B-33.4% | -$1.7B | -$1.7B-45.0% | -$1.1B |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
ALVOW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
ALVOW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$284.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Alvotech Warrant Ranks
Frequently Asked Questions
What is Alvotech Warrant's annual revenue?
Alvotech Warrant (ALVOW) reported $586.3M in total revenue for fiscal year 2025. This represents a 19.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Alvotech Warrant's revenue growing?
Alvotech Warrant (ALVOW) revenue grew by 19.7% year-over-year, from $489.7M to $586.3M in fiscal year 2025.
Is Alvotech Warrant profitable?
Yes, Alvotech Warrant (ALVOW) reported a net income of $27.9M in fiscal year 2025, with a net profit margin of 4.8%.
How much debt does Alvotech Warrant have?
As of fiscal year 2025, Alvotech Warrant (ALVOW) had $172.4M in cash and equivalents against $138.0M in long-term debt.
What is Alvotech Warrant's net profit margin?
Alvotech Warrant (ALVOW) had a net profit margin of 4.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Alvotech Warrant's free cash flow?
Alvotech Warrant (ALVOW) recorded an outflow of $114.7M in free cash flow during fiscal year 2025. This represents a 60.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Alvotech Warrant's operating cash flow?
Alvotech Warrant (ALVOW) recorded an outflow of $50.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Alvotech Warrant's total assets?
Alvotech Warrant (ALVOW) had $1.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Alvotech Warrant's capital expenditures?
Alvotech Warrant (ALVOW) invested $64.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Alvotech Warrant's current ratio?
Alvotech Warrant (ALVOW) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.
What is Alvotech Warrant's return on assets (ROA)?
Alvotech Warrant (ALVOW) had a return on assets of 1.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Alvotech Warrant's debt-to-equity ratio negative or not reported?
Alvotech Warrant (ALVOW) has negative shareholder equity of -$284.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Alvotech Warrant's Piotroski F-Score?
Alvotech Warrant (ALVOW) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Alvotech Warrant's earnings high quality?
For every $1 of reported earnings, Alvotech Warrant (ALVOW) used $1.80 of operating cash (-$50.2M OCF vs $27.9M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.